In order to answer this question, we inhibited KRAS by a combination of farnesyltransferase inhibition (FTI) and geranylgeranyltransferase inhibition (GGTI) in NSCLC cells and examined Crk phosphorylation. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.